The emergence of the strain of coronavirus SARS-CoV-2 (severe acute respiratory syndrome coronavirus 2) that causes corona virus disease 2019 (COVID-19) and its impact on in the world have made imperative progress to develop an effective and safe vaccine. Despite several measures undertaken, the spread of this virus is ongoing. So far, more than 1,560,000 cases and 1000,000 deaths occurred in the world. Efforts have been made to develop vaccines against human coronavirus (CoV) infections such as MERS and SARS. However, currently, no approved vaccine exists for these coronavirus strains. Such Previous research efforts to develop a coronavirus vaccine in the years following the 2003 pandemic have opened the door for the scientist to design a new vaccine for the COVID-19. Both SARS-CoV and SARS-CoV-2 has a high degree of genetic similarity and bind to the same host cell ACE2 receptor. By using different vaccine development platforms including whole virus vaccines, recombinant protein subunit vaccines, and nucleic acid vaccines several candidates displayed efficacy in vitro studies but few progressed to clinical trials. This review provides a brief introduction of the general features of SARS-CoV-2 and discusses the current progress of ongoing advances in designing vaccine development efforts to counter COVID-19.Biopolymers have been used in packaged foods to tackle environmental hazards due to their biodegradability and non-toxic nature. In addition to these merits, they have also several demerits such as poor mechanical properties and low resistance towards water. Nanomaterials have attracted great interest in recent years due to their phenomenal properties that makes them precedent in applications for food packaging as they enhance the mechanical, thermal and gas barriers properties, without compromising with the ability to become non-toxic and biodegradable. The most important nanomaterials used in food packaging are montmorillonite (MMT), zinc oxide (ZnO-NPs) coated silicate, kaolinite, silver NPs (Ag-NPs) and titanium dioxide (TiO2NPs) as these, nanomaterials coated films makes a barrier against oxygen, carbon dioxide and favour compounds. They also possess oxygen scavenging capability, antimicrobial activity and tolerance towards temperature. The most difficult task related to the preparation of these nanocomposites is their complete distribution within the polymer matrix and their compatibility. Therefore, there is an increasing demand for improvement in the performance of nano-packaging materials including mechanical stability, degradability and effectiveness of antibacterial property.
The objective of this study is to test whether recorded rates of violent crime declined in the context of social distancing regulations in Queensland, Australia.
ARIMA modeling was used to compute 6-month-ahead forecasts of rates for common assault, serious assault, sexual offenses, and breaches of domestic violence orders. selleck These forecasts (and their 95% confidence intervals) are compared to the observed data for March and April 2020.
By the end of April, 2020, rates of common, serious, and sexual assault had declined to their lowest level in a number of years. For serious assault and sexual assault, the decline was beyond statistical expectations. The rate at which domestic violence orders were breached remained unchanged.
Social distancing regulations are temporally correlated with reductions in some violent crimes. Social distancing is likely to have significantly limited interpersonal interaction, especially in locations and at times when violence is usually prevalent.
Social distancing regulations are temporally correlated with reductions in some violent crimes. Social distancing is likely to have significantly limited interpersonal interaction, especially in locations and at times when violence is usually prevalent.A freshwater alkaliphilic strain of Pseudomonas aeruginosa, grown on waste frying oil-basal medium, produced a surface-active metabolite identified as glycolipopeptide. Bioprocess conditions namely temperature, pH, agitation and duration were comparatively modeled using statistical and artificial neural network (ANN) methods to predict and optimize product yield using the matrix of a central composite rotatable design (CCRD). Response surface methodology (RSM) was the statistical approach while a feed-forward neural network, trained with Levenberg-Marquardt back-propagation algorithm, was the neural network method. Glycolipopeptide model was predicted by a significant (P less then 0.001, R2 of 0.9923) quadratic function of the RSM with a mean squared error (MSE) of 3.6661. The neural network model, on the other hand, returned an R2 value of 0.9964 with an MSE of 1.7844. From all error metrics considered, ANN glycolipopeptide model significantly (P less then 0.01) outperformed RSM counterpart in predictive modeling capability. Optimization of factor levels for maximum glycolipopeptide concentration produced bioprocess conditions of 32 °C for temperature, 7.6 for pH, agitation speed of 130 rpm and a fermentation time of 66 h, at a combined desirability function of 0.872. The glycosylated lipid-tailed peptide demonstrated significant anti-bacterial activity (MIC = 8.125 µg/mL) against Proteus vulgaris, dose-dependent anti-biofilm activities against Escherichia coli (83%) and Candida dubliniensis (90%) in 24 h and an equally dose-dependent cytotoxic activity against human breast (MCF-7 IC50 = 65.12 µg/mL) and cervical (HeLa IC50 = 16.44 µg/mL) cancer cell lines. The glycolipopeptide compound is recommended for further studies and trials for application in human cancer therapy.Cervical cancer is the second most common leading cause of women's death due to cancer worldwide, about 528,000 patients' cases and 266,000 deaths per year, related to human papillomavirus (HPV). Peptide-based vaccines being safe, stable, and easy to produce have demonstrated great potential to develop therapeutic HPV vaccine. In this study, the major histocompatibility complex (MHC) class I, class II T cell epitopes of HPV16-E7 were predicted. Therefore, we designed a plan to find the most effective peptides to prompt appropriate immune responses. For this purpose, retrieving protein sequences, conserved region identification, phylogenic tree construction, T cell epitope prediction, epitope-predicted population coverage calculation, and molecular docking were performed consecutively and most effective immune response prompting peptides were selected. Based on different tools index, six CD8+ T cells and six CD4+ epitopes were chosen. This combination of 12 epitopes created a putative global vaccine with a 95.selleck
Top comments (0)